Elsevier

Tetrahedron Letters

Volume 52, Issue 19, 11 May 2011, Pages 2440-2442
Tetrahedron Letters

Biocatalytic strategy toward asymmetric β-hydroxy nitriles and γ-amino alcohols

https://doi.org/10.1016/j.tetlet.2011.03.009Get rights and content

Abstract

A library of 20 bakers’ yeast reductases, that are overexpressed in Escherichia coli, were screened against a variety of β-keto nitriles. Enzymes from the aldose reductase and the short chain dehydrogenase family displayed activity toward these substrates. All of the seven substrates were reduced with high enantioselectivities and in some cases both antipodes could be synthesized in high ees. These whole-cell reactions afforded gram quantities of asymmetric compounds that could ultimately lead to scaleable and simple synthesis to new drug analogs of serotonin reuptake inhibitors and β-adrenergic blocking agents.

Introduction

Asymmetric β-hydroxy nitriles are excellent chiral precursors due to their reactive diversity (Scheme 1). These asymmetric products have been used to make a variety of chiral natural products and pharmaceuticals.1, 2, 3 The most popular example is the utilization of β-hydroxy nitriles 1 or γ-amino alcohols 2 in the synthesis of the serotonin reuptake inhibitors4, 5, 6 and β-adrenergic blocking agents.7, 8, 9

Chiral organic10, 11, 12 and inorganic13, 14, 15, 16, 17, 18, 19, 20 catalysts have both been investigated in the synthesis of these molecules. The main disadvantage to these strategies is that the catalysts often involve a difficult synthesis and have toxicity issues especially when considering the use of heavy metals for the synthesis of pharmaceuticals. In addition, high enantioselectivity is often difficult to achieve.

Biocatalytic strategies utilizing isolated enzymes have also been a strategy toward asymmetric β-hydroxy nitriles 1.21, 22, 23 The most popular examples use a lipase or nitrilase to catalyze the kinetic resolution of the racemic β-hydroxy nitrile.4, 24, 25, 26, 27 However, these enzymes are inherently limited to a 50% yield when resolving the racemate. The reduction of β-keto nitriles using isolated keto reductases has recently been investigated; however, the cofactor must be supplied or a cofactor regeneration system used when working with pure enzymes.28, 29

Whole-cell biocatalytic strategies have also been investigated for the reduction of β-keto nitriles. This is advantageous because the cell will supply the cofactors needed for the reduction resulting in affordable and simple reaction conditions. However, studies using Curvularia lunata and bakers’ yeast (Saccharomyces cerevisiae) to reduce these substrates have been plagued by a dominant alkylating mechanism (Scheme 2).30, 31, 32, 33, 34, 35

Bakers’ yeast (S. cerevisiae) has been a popular biocatalytic tool that has been investigated to achieve a variety of reductions.36 Its ability to reduce an assortment of ketone substrates is ultimately due to the many keto reductases this organism contains.37 Unfortunately, this large number of reductases often leads to a mixture of products formed by competing enzymes. To circumvent this problem, GST-reductase chimeras were engineered and placed into Escherichia coli creating a bakers’ yeast reductase library.37, 38, 39 We have used this system to screen the stereospecificity of a single reductase for a given substrate by use of the pure fusion protein or in whole-cells.39, 40, 41

Section snippets

Results and discussion

This manuscript reports the screening of this heterologous library for its ability to asymmetrically reduce a variety of β-keto nitriles. The simplicity of this system lies in the fact that it uses whole-cells to supply the cofactors, minimizes competing reactions by overexpressing a single yeast reductase, and is scaleable thus it is well suited for the synthetic chemist who desires gram quantities.

The asymmetric reduction of a variety of alkyl and aryl substituted β-keto nitriles were

Conclusions

Asymmetric β-hydroxy nitriles are chiral precursors which have been applied to the synthesis of serotonin reuptake inhibitors4, 5, 6 and β-adrenergic blocking agents.7, 8, 9 We have shown a simple and scaleable approach to make a variety of asymmetric β-hydroxy nitriles while avoiding the alkylated product often seen with whole-cell biocatalysis. In most cases these products are reduced with very high stereospecificity and there are also examples in which both antipodes can be synthesized by

Acknowledgments

This work was supported by NSF-RUI grant CHE-0848708 from the Organic and Macromolecular Chemistry Program and NSF-MRI CHE-0923153. Additional thanks to Jon Stewart at the University of Florida for donating the enzyme library in these studies.

References and notes (43)

  • Y. Fukuda et al.

    Tetrahedron

    (2002)
  • A. Kamal et al.

    Bioorg. Med. Chem. Lett.

    (2005)
  • A. Kamal et al.

    Tetrahedron: Asymmetry

    (2002)
  • R.J. Hammond et al.

    Tetrahedron Lett.

    (2007)
  • A. Kamal et al.

    Tetrahedron: Asymmetry

    (2005)
  • K. Soai et al.

    Tetrahedron: Asymmetry

    (1992)
  • J. Granander et al.

    Tetrahedron: Asymmetry

    (2006)
  • N. Kumagai et al.

    Tetrahedron

    (2007)
  • R.K. Pandey et al.

    Tetrahedron Lett.

    (2002)
  • T. Itoh et al.

    Tetrahedron Lett.

    (1989)
  • A.J. Smallridge et al.

    Tetrahedron Lett.

    (1998)
  • J.R. Dehli et al.

    Tetrahedron: Asymmetry

    (2000)
  • B.D. Feske et al.

    Tetrahedron: Asymmetry

    16

    (2005)
  • J.D. Stewart

    Adv. Appl. Microbiol.

    (2006)
  • S.D. Keegen et al.

    Tetrahedron: Asymmetry

    (1996)
  • D. Mitchell et al.

    Synth. Commun.

    (1995)
  • B.G. Main et al.

    Medicinal Chemistry: The role of Organic Chemistry in Drug Research of Beta Blockers

  • A.F. Crowther et al.

    J. Med. Chem.

    (1968)
  • B.T. Chao et al.

    Bull. Korean Chem. Soc.

    (2002)
  • Y. Suto et al.

    Org. Lett.

    (2005)
  • M. Watanabe et al.

    Org. Chem.

    (2002)
  • Cited by (18)

    • 1,3-Amino alcohols and their phenol analogs in heterocyclization reactions

      2020, Advances in Heterocyclic Chemistry
      Citation Excerpt :

      Consequently, efficient new methods for the enantio- and diastereoselective preparation of this compound class are in high demand. The most studied methods for the synthesis of 1,3-amino alcohol motifs include assembly (often asymmetric) of β-amino ketones/aldehydes (2018OM2837, 2018NC523, 2018TL559), β-hydroxy (or boryl) imines (2014OBC6121, 2013OL4810, 2012JFC102), β-hydroxy enamines (2010JA14179), β-lactams (2009JMC4058, 2016SL1100), β-hydroxy nitriles/amides (2018OL7371, 2018CCC2868, 2011TL2440), β-azido ketones (2016OPRD474), or γ-azido alcohols/aldehydes (2010T5036, 2007SC1027) with their subsequent reduction. Among other reductive processes are reduction of β-amino acids or their esters (2017COS612, 2015NJC3295, 2014EJO7148), Ru-catalyzed reductive hydration of propargylic amines (2015JOC8604), reductive elimination of iodomethyltetrahydropyrans accessible via Prins/Ritter reaction sequence (2013OL546) and one-pot three-step syn-selective aza-aldol reaction of boron azaenolates, generated from N-sulfonyl-1,2,3-triazoles and 9-BBN-H with subsequent reduction of β-oxygenated imines (2016AGE8732), regioselective hydrosilylation of α-hydroxy aziridines (2018AGE13528).

    • Efficient methodology to produce a duloxetine precursor using whole cells of Rhodotorula rubra

      2016, Tetrahedron Asymmetry
      Citation Excerpt :

      A valid alternative emerging for the production of these useful intermediates is the use of biocatalysts, i.e. the kinetic resolution starting from racemic mixtures of β-hydroxynitriles catalyzed by lipases and nitrilases10–12 or the enantioselective reduction of β-ketonitriles catalyzed by ketoreductases.13–15 Over the last decade different isolated carbonyl reductases have been employed in the reduction of these valuable precursors although their application was correlated to the presence of redox cofactors thus inevitably introducing the need for fine tuning the appropriate cofactor recycle system.16–19 In contrast, the use of whole cells could overcome this unprofitable drawback.

    • Preparation of enantiomerically enriched aromatic β-hydroxynitriles and halohydrins by ketone reduction with recombinant ketoreductase KRED1-Pglu

      2016, Tetrahedron
      Citation Excerpt :

      The most popular example of the utilization of optically pure β-hydroxynitriles is the synthesis of serotonin/norepinephrine reuptake inhibitors for the treatment of depressive or sleep disorders, anxiety, alcoholism, chronic pain, obesity and anorexia or bulimia.9,12 Although reduction of aromatic β-ketonitriles can be obtained by chemical chiral catalysts,13,14 biocatalysis has proved to be an efficient and green alternative; biocatalytic reduction is mostly performed with isolated enzymes,15–18 since the use of whole cells is often limited by the occurrence of a—competitive ethylation, resulting from non-enzymatic aldol condensation between aromatic β-ketonitriles and acetaldehyde (formed by the whole cells in the presence of glucose or ethanol), followed by reduction of the activated CC by enoate reductases.19–23 Optically pure aromatic halohydrins are versatile synthons that have been used for the synthesis of many pharmaceuticals, including drugs for psychiatric disorders, such as (R)-Fluoxetine,24–27 (R)-Duloxetine,27,28 or (R)-Ibutilide, an antiarrhythmic agent.29

    • A single point mutation enhances hydroxynitrile synthesis by halohydrin dehalogenase

      2015, Enzyme and Microbial Technology
      Citation Excerpt :

      Nitrile groups can in turn be enzymatically converted to amides [7] or carboxylates [8,9]. Some β-hydroxynitriles can be prepared via biocatalytic approaches, such as reduction of β-keto nitriles [10,11] and lipase-catalyzed hydrolysis of β-hydroxynitrile acetates [12–16]. An alternative biocatalytic conversion yielding β-hydroxynitriles is the ring-opening of epoxides with cyanide as a nucleophile, a reaction catalyzed by halohydrin dehalogenases [17–20] (Fig. 1).

    View all citing articles on Scopus
    View full text